Frans Vos received HollandPTC consortium grant for proton therapy research

Nieuws - 12 oktober 2018 - Communication ImPhys

Dr. Frans Vos (TU Delft) and Thijs van Osch (LUMC)

New methodology for developing biomarkers of radiation-induced toxicity in brain tumour patients based on advanced MR imaging of the microvasculature and white matter microstructure. 


10 researchers were awarded with grants from the first HollandPTC-Varian consortium-confined call. In total €2,7M of funding will be used to boost the joint research between Erasmus MC, LUMC and TU Delft in the field of proton therapy. This is an important step towards realising the best possible proton treatment and finding proof of proton therapy efficacy.

Cooperation between the consortium partners is key. Marco van Vulpen, medical director and chair of the HollandPTC R&D programme board: “HollandPTC is an open research facility for all researchers within the field of proton therapy and we believe this cooperation facilitates and strengthens research and will lead to better results. We congratulate the researchers with their grants and welcome them to our research facility.”

More information on proton therapy research can be found here or on the website of HollandPTC.